Social Media: A Matter of Survival for Biopharma
By Mari Serebrov
Monday, December 12, 2011
With the biopharma industry more regulated, more restricted, more competitive and more vilified than ever before, it can't afford to be paralyzed by the FDA's lack of social media guidance.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.